ID

14405

Description

A Comparison of Levalbuterol Plus Ipratropium With Levalbuterol Alone in the Treatment of Acute Asthma Exacerbation; ODM derived from: https://clinicaltrials.gov/show/NCT00583778

Link

https://clinicaltrials.gov/show/NCT00583778

Keywords

Versions (1)
  1. 4/13/16 4/13/16 -
Copyright Holder

CC BY-NC 3.0

Uploaded on

April 13, 2016

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Asthma NCT00583778

English

Eligibility Asthma NCT00583778

1 forms  
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00583778
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
18-45 years of age
Description

age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
history of asthma
Description

asthma

Data type

boolean

Alias
UMLS CUI [1]
C0004096
fev1 > 50% of predicted for their height, age, gender and race upon presentation to the ed
Description

fev1

Data type

boolean

Alias
UMLS CUI [1]
C0748133
no other cause of wheezing or shortness of breath except for asthma as determined by the investigator
Description

no other cause of wheezing or shortness of breath

Data type

boolean

Alias
UMLS CUI [1]
C0043144
UMLS CUI [2]
C0013404
no history of glaucoma
Description

glaucoma

Data type

boolean

Alias
UMLS CUI [1]
C0017601
no ipratropium or other anticholinergics within 6 hours of study
Description

ipratropium or other anticholinergics

Data type

boolean

Alias
UMLS CUI [1]
C0700580
UMLS CUI [2]
C0242896
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
subjects who, in the investigator's opinion, have life-threatening asthma requiring emergent intervention precluding the ability to complete the treatments during the treatment period
Description

life-threatening asthma

Data type

boolean

Alias
UMLS CUI [1,1]
C0004096
UMLS CUI [1,2]
C2826244
UMLS CUI [2]
C0013956
based upon history or physical exam in the ed orclinic, subjects with known or suspected cause of pulmonary symptoms other than asthma, such as copd, chf, pneumonia, pulmonary embolism, or angioedema
Description

respiratory disease

Data type

boolean

Alias
UMLS CUI [1]
C0035204
subject with a known sensitivity to levalbuterol or racemic albuterol
Description

sensitivity to levalbuterol or racemic albuterol

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0772501
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C2957898
known 20 pack year smoker
Description

smoking history

Data type

boolean

Alias
UMLS CUI [1]
C1519384
UMLS CUI [2]
C1277691
use of ipratropium 6 hours prior to presenting to the ed
Description

ipratropium

Data type

boolean

Alias
UMLS CUI [1,1]
C0700580
UMLS CUI [1,2]
C0040223
subject who may be pregnant or is pregnant es evidenced by pregnancy test
Description

pregnancy

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0032976
Back to the top of the page

Similar models

Eligibility Asthma NCT00583778

1 forms
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00583778
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
18-45 years of age
boolean
C0001779 (UMLS CUI [1])
asthma
Item
history of asthma
boolean
C0004096 (UMLS CUI [1])
fev1
Item
fev1 > 50% of predicted for their height, age, gender and race upon presentation to the ed
boolean
C0748133 (UMLS CUI [1])
no other cause of wheezing or shortness of breath
Item
no other cause of wheezing or shortness of breath except for asthma as determined by the investigator
boolean
C0043144 (UMLS CUI [1])
C0013404 (UMLS CUI [2])
glaucoma
Item
no history of glaucoma
boolean
C0017601 (UMLS CUI [1])
ipratropium or other anticholinergics
Item
no ipratropium or other anticholinergics within 6 hours of study
boolean
C0700580 (UMLS CUI [1])
C0242896 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
life-threatening asthma
Item
subjects who, in the investigator's opinion, have life-threatening asthma requiring emergent intervention precluding the ability to complete the treatments during the treatment period
boolean
C0004096 (UMLS CUI [1,1])
C2826244 (UMLS CUI [1,2])
C0013956 (UMLS CUI [2])
respiratory disease
Item
based upon history or physical exam in the ed orclinic, subjects with known or suspected cause of pulmonary symptoms other than asthma, such as copd, chf, pneumonia, pulmonary embolism, or angioedema
boolean
C0035204 (UMLS CUI [1])
sensitivity to levalbuterol or racemic albuterol
Item
subject with a known sensitivity to levalbuterol or racemic albuterol
boolean
C0020517 (UMLS CUI [1,1])
C0772501 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C2957898 (UMLS CUI [2,2])
smoking history
Item
known 20 pack year smoker
boolean
C1519384 (UMLS CUI [1])
C1277691 (UMLS CUI [2])
ipratropium
Item
use of ipratropium 6 hours prior to presenting to the ed
boolean
C0700580 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
pregnancy
Item
subject who may be pregnant or is pregnant es evidenced by pregnancy test
boolean
C0032961 (UMLS CUI [1])
C0032976 (UMLS CUI [2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial